ClinicalTrials.gov
ClinicalTrials.gov Menu

Immunologic Analysis of Peripheral Blood and Aspirated Thromb In AMI Patients (ATAIA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT02704806
Recruitment Status : Unknown
Verified March 2016 by Mingyou Zhang, Jilin University.
Recruitment status was:  Not yet recruiting
First Posted : March 10, 2016
Last Update Posted : March 10, 2016
Sponsor:
Information provided by (Responsible Party):
Mingyou Zhang, Jilin University

Brief Summary:
Researchers use FCM to analyze the immunol cell feature and its corresponding activation status, as well as the thromb aspirated through the thromb aspiration device in AMI patients

Condition or disease
Immunol Feature in Circulation and Thromb in AMI Patients

Study Type : Observational
Estimated Enrollment : 60 participants
Observational Model: Case Control
Time Perspective: Prospective
Official Title: Immunologic Analysis of Aspired Thromb and Circulatory Immune Cell in AMI Patients
Study Start Date : April 2016
Estimated Primary Completion Date : April 2017
Estimated Study Completion Date : April 2018



Primary Outcome Measures :
  1. immunologic feature of AMI patients [ Time Frame: 1 month ]

Biospecimen Retention:   Samples With DNA
Thromb will be abtained with aspiration device during PCI intervention, peripheral blood will be abtained as well for study.


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   30 Years to 80 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
Acute myocardial infarction patients
Criteria

Inclusion Criteria:

  • uncomplicated AMI patients

Exclusion Criteria:

  • any self immune disease and recent (within 1 month) or any chronic infection

Responsible Party: Mingyou Zhang, attending physician, Jilin University
ClinicalTrials.gov Identifier: NCT02704806     History of Changes
Other Study ID Numbers: Cthromb20160401
First Posted: March 10, 2016    Key Record Dates
Last Update Posted: March 10, 2016
Last Verified: March 2016